Atyr Pharma Inc
NASDAQ:ATYR
| Market Cap (Intraday) | 530.12M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.19 |
| 50-Day MA | $5.30 |
| 200-Day MA | $4.03 |
Atyr Pharma Inc Stock, NASDAQ:ATYR
10240 Sorrento Valley Road, Suite 300, San Diego, California 92121
United States of America
Phone: +1.858.731.8389
Number of Employees: 59
Description
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.